Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 May 11;9(2):E128-47.
doi: 10.1208/aapsj0902015.

Targeted pharmaceutical nanocarriers for cancer therapy and imaging

Vladimir P Torchilin  1
Affiliations
Review

Targeted pharmaceutical nanocarriers for cancer therapy and imaging

Vladimir P Torchilin. AAPS J. .

Abstract

The use of various pharmaceutical nanocarriers has become one of the most important areas of nanomedicine. Ideally, such carriers should be specifically delivered (targeted) to the pathological area to provide the maximum therapeutic efficacy. Among the many potential targets for such nanocarriers, tumors have been most often investigated. This review attempts to summarize currently available information regarding targeted pharmaceutical nanocarriers for cancer therapy and imaging. Certain issues related to some popular pharmaceutical nanocarriers, such as liposomes and polymeric micelles, are addressed, as are different ways to target tumors via specific ligands and via the stimuli sensitivity of the carriers. The importance of intracellular targeting of drug- and DNA-loaded pharmaceutical nanocarriers is specifically discussed, including intracellular delivery with cell-penetrating peptides.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Torchilin VP, editor. Nanoparticulates as Pharmaceutical Carriers. London, UK: Imperial College Press; 2006.
    1. Müller RH. Colloidal carriers for controlled drug delivery and targeting: modification, characterization, and in vivo distribution. Stuttgart, Germany, and Boca Raton, FL: Wissenschaftliche Verlagsgesellschaft and CRC Press; 1991.
    1. Cohen S, Bernstein H, editors. Microparticulate Systems for the Delivery of Proteins and Vaccines. New York, NY: Marcel Dekker; 1996.
    1. Gref R, Minamitake Y, Peracchia MT, et al. Biodegradable long-circulating polymeric nanospheres. Science. 1994;263:1600–1603. doi: 10.1126/science.8128245. - DOI - PubMed
    1. Maeda H. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv Drug Deliv Rev. 2001;46:169–185. doi: 10.1016/S0169-409X(00)00134-4. - DOI - PubMed

MeSH terms

LinkOut - more resources